Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Zha, Xianfeng ^a   Yan, Xiaojuan ^a   Shen, Qi ^a   Zhang, Yuping ^b   Wu, Xiuli ^a   Chen, Shaohua ^a   Li, Bo ^a   Yang, Lijian ^a   Geng, Suxia ^c   Weng, Jianyu ^c   Du, Xin ^c   Li, Yangqiu ^a,d  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

ASF SF 2gene; Chronic myeloid leukemia; Fc RI gene; Real time PCR; TCR gene; TCR 3 UTR

Indexed keywords

IMATINIB; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; YOUNG ADULT; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84872316756     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-74     Document Type: Article

References (43)

1. Antigens in chronic myeloid leukemia: implications for vaccine development. Smahel M, Cancer Immunol Immun 2011 60 1665 1668
2. TCR zeta chain expression in T cells from patients with CML. Chen S, Yang L, Chen S, Li Y, Hematology 2009 14 95 100 10.1179/102453309X385241 19298721
3. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M, Br J Haematol 2000 111 817 825 10.1046/j.1365-2141.2000.02415.x 11122143 (Pubitemid 32098920)
4. Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Li Y, Hematology 2008 13 267 275 10.1179/102453308X343482 18854088
5. Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients. Li Y, Geng S, Du X, Chen S, Yang L, Wu X, Li B, Schmidt CA, Przybylski GK, Hematology 2011 16 43 49 10.1179/102453311X12902908411634 21269567
6. Decreased level of recent thymic emigrants in CD4+ and CD8 + T cells from CML patients. Li Y, Geng S, Yin Q, Chen S, Yang L, Wu X, Li B, Du X, Schmidt CA, Przybylski GK, J Transl Med 2010 8 47 10.1186/1479-5876-8-47 20470401
7. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Call ME, Wucherpfennig KW, Annu Rev Immunol 2005 23 101 125 10.1146/annurev.immunol.23.021704.115625 15771567 (Pubitemid 40563166)
8. Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. Call ME, Pyrdol J, Wucherpfennig KW, EMBO J 2004 23 2348 2357 10.1038/sj.emboj.7600245 15152191 (Pubitemid 38954842)
9. The T cell receptor/CD3 complex: a dynamic protein ensemble. Clevers H, Alarcon B, Wileman T, Terhorst C, Annu Rev Immunol 1988 6 629 662 10.1146/annurev.iy.06.040188.003213 3289580 (Pubitemid 19141599)
10. CD3 deficiencies. Fischer A, de Saint Basile G, Le Deist F, Curr Opin Allergy Clin Immunol 2005 5 491 495 10.1097/01.all.0000191886.12645.79 16264327 (Pubitemid 41679982)
11. ZAP70: a master regulator of adaptive immunity. Fischer A, Pieard C, Chemin K, Semin Immunopathol 2010 32 107 116 10.1007/s00281-010-0196-x 20135127
12. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Enyedy EJ, Nambiar MP, Liossis SN, Dennis G, Kammer GM, Tsokos GC, Arthritis Rheum 2001 44 1114 1121 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3. 0.CO;2-B 11352243 (Pubitemid 32433617)
13. T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes. Koyasu S, D'Adamio L, Arulanandam AR, Abraham S, Clayton LK, Reinherz EL, J Exp Med 1992 175 203 209 10.1084/jem.175.1.203 1530959
14. Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage. Mozaffari F, Hansson L, Kiaii S, Ju X, Rossmann ED, Rabbani H, Mellstedt H, Osterborg A, Br J Haematol 2004 124 315 324 10.1046/j.1365-2141.2003.04789.x 14717778 (Pubitemid 38167981)
15. Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients. Chen S, Zha X, Yang L, Li B, Liye Z, Li Y, Hematology 2011 16 31 36 10.1179/102453311X12902908411832 21269565
16. Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3'-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. Chowdhury B, Tsokos CG, Krishnan S, Robertson J, Fisher CU, Warke RG, Warke VG, Nambiar MP, Tsokos GC, J Biol Chem 2005 280 18959 18966 10.1074/jbc.M501048200 15743765 (Pubitemid 41379599)
17. Organization of the human T cell receptor zeta/eta gene and its genetic linkage to the Fc gamma RII-Fc gamma RIII gene cluster. Jensen JP, Hou D, Ramsburg M, Taylor A, Dean M, Weissman AM, J Immunol 1992 148 2563 2571 1532817
18. Up-regulation of α E 7, a novel integrin adhesion molecule, on T cells from systemic lupus erythematosus patients with specific epithelial involvement. Pang M, Abe T, Fujihara T, Mori S, Tsuzaka K, Amano K, Koide J, Takeuchi T, Arthritis Rheum 1998 41 1456 1463 10.1002/1529-0131(199808)41: 8<1456::AID-ART16>3.0.CO;2-0 9704645 (Pubitemid 28373126)
19. Alternative Splicing Factor/Splicing Factor 2 Regulates the Expression of the ζ Subunit of the Human T Cell Receptor-associated CD3 Complex. Moulton VR, Tsokos GC, J Biol Chem 2010 285 12490 12496 10.1074/jbc.M109.091660 20118245
20. TCR kappa, a new splicing of the murine TCR zeta gene locus, is modulated by glucocorticoid treatment. Giunchi L, Nocentini G, Ronchetti S, Bartoli A, Riccardi C, Migliorati G, Mol Cell Biochem 1999 195 47 53 10.1023/A: 1006925927551 10395068 (Pubitemid 29259768)
21. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus. Takeuchi T, Tsuzaka K, Pang M, Amano K, Koide J, Abe T, Int Immunol 1998 10 911 921 10.1093/intimm/10.7.911 9701029 (Pubitemid 28325607)
22. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African American pedigrees. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, et al. Proc Natl Acad Sci USA 1998 95 14869 14874 10.1073/pnas.95.25.14869 9843982 (Pubitemid 29003723)
23. Polymorphisms/Mutations of TCR-ζ-Chain Promoter and 3′Untranslated Region and Selective Expression of TCR ζ-Chain with an Alternatively Spliced 3′Untranslated Region in Patients with Systemic Lupus Erythematosus. Nambiar MP, Enyedy EJ, Warke VG, Krishnan S, Dennis G, Kammer GM, Tsokos GC, J Autoimmunol 2001 16 133 142 10.1006/jaut.2000.0475 (Pubitemid 32552988)
24. Genome- wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD, Science 2003 302 2141 2144 10.1126/science.1090100 14684825 (Pubitemid 38017950)
25. Mechanisms of alternative pre-messenger RNA splicing. Black DL, Annu Rev Biochem 2003 72 291 336 10.1146/annurev.biochem.72.121801.161720 12626338 (Pubitemid 36930448)
26. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Cáceres JF, Stamm S, Helfman DM, Krainer AR, Science 1994 265 1706 1709 10.1126/science.8085156 8085156 (Pubitemid 24314901)
27. Purification and characterization of premRNA splicing factor SF2 from HeLa cells. Krainer AR, Conway GC, Kozak D, Genes Dev 1990 4 1158 1171 10.1101/gad.4.7.1158 2145194
28. New talents for an old acquaintance: the SR protein splicing factor ASF/SF2 functions in the maintenance of genome stability. Li XL, Manley JL, Cell Cycle 2005 4 1706 1708 10.4161/cc.4.12.2210 16294036 (Pubitemid 41827307)
29. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early premRNA in vitro. Ge H, Manley JL, Cell 1990 62 25 34 10.1016/0092-8674(90)90236-8 2163768 (Pubitemid 20216282)
30. The superfamily of arginine/serine-rich splicing factors. Fu XD, RNA 1995 1 663 680 7585252
31. Multiple roles of the SR protein family in splicing regulation. Sanford JR, Longman D, Caceres JF, Prog Mol Subcell Biol 2003 31 33 58 12494762
32. SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness. Massiello A, Chalfant CE, J Lipid Res 2006 47 892 899 10.1194/jlr.C600003-JLR200 16505493 (Pubitemid 43764686)
33. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Lemaire R, Winne A, Sarkissian M, Lafyatis R, EUR J IMMUN 1999 29 823 837 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C (Pubitemid 29119061)
34. BCR-ABL1-independent P13Kinase activation causing imatinib-resistance. Quentmeier H, Eberth S, Romani J, Zaborski M, Drexler HG, J Hematol Oncol 2011 4 6 10.1186/1756-8722-4-6 21299849
35. The RNA-stabilizing Protein HuR Regulates the Expression of Chain of the Human T Cell Receptor-associated CD3 Complex. Moulton VR, Kyttaris VC, Juang YT, J Biol Chem 2008 283 20037 20044 10.1074/jbc.M710434200 18505733
36. Expression feature of CD3, FcεRIγ and Zap-70 in patients with chronic lymphocytic leukemia. Huang L, Chen S, Zha X, Yang L, Li B, Yu Z, Wang L, Li Y, Hematology 2012 17 71 75 22664044
37. Up-regulated TCRζ enhances interleukin-2 production in T-cells from patients with CML. Zha X, Chen S, Yang L, Shi L, Li B, Wu X, Lu Y, Li Y, DNA Cell Biol 2012 in press
38. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. Shiue L, Zoller MJ, Brugge JS, J Biol Chem 1995 270 10498 10502 10.1074/jbc.270.18.10498 7537732
39. Inhibition of mast cell FcÂ"RI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. Oliver JM, Burg D, Wilson BS, McLaughlin JL, Geahlen RL, J Biol Chem 1994 269 29697 29703 7961959
40. Differential activation of the tyrosine kinases ZAP-70 and Syk after FcgRI stimulation. Taylor N, Jahn T, Smith S, Lamkin T, Uribe L, Liu Y, Blood 1997 89 388 396 9002939 (Pubitemid 27051672)
41. ZAP-70: an essential Kinase in T-cell signaling. Wang H, Kadlecek TA, Au-Yeung BB, Goodfellow HE, Hsu LY, Freedman TS, Weiss A, Cold Spring Harb Perspect Biol 2010 2 002279 10.1101/cshperspect.a002279 20452964
42. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Baniyash M, Nat Rev Immunol 2004 4 675 687 10.1038/nri1434 15343367 (Pubitemid 39223074)
43. Signaling defects in T lymphocytes of patients with malignancy. Whiteside TL, Cancer Immunol Immun 1999 48 346 352 (Pubitemid 29461386)